Evelina Vågesjö
Post doctoral at Department of Medical Cell Biology; Research Group Mia Phillipson
- Telephone:
- +46 18 471 43 24
- E-mail:
- Evelina.Vagesjo@mcb.uu.se
- Visiting address:
- BMC
Husargatan 3
751 23 Uppsala - Postal address:
- Box 571
751 23 UPPSALA
Publications
Recent publications
Corpora cavernosa fibroblasts mediate penile erection
Part of Science, 2024
Part of American Journal of Physiology - Gastrointestinal and Liver Physiology, 2024
- DOI for Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models
- Download full text (pdf) of Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models
Part of eClinicalMedicine, 2023
- DOI for Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial
- Download full text (pdf) of Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial
Part of Pharmaceutics, 2022
- DOI for Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria
- Download full text (pdf) of Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria
How can we optimize the development of drugs for wound healing?
Part of Expert Opinion on Drug Discovery, p. 93-96, 2022
All publications
Articles in journal
Corpora cavernosa fibroblasts mediate penile erection
Part of Science, 2024
Part of American Journal of Physiology - Gastrointestinal and Liver Physiology, 2024
- DOI for Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models
- Download full text (pdf) of Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models
Part of eClinicalMedicine, 2023
- DOI for Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial
- Download full text (pdf) of Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial
Part of Pharmaceutics, 2022
- DOI for Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria
- Download full text (pdf) of Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria
How can we optimize the development of drugs for wound healing?
Part of Expert Opinion on Drug Discovery, p. 93-96, 2022
Perivascular macrophages regulate blood flow following tissue damage
Part of Circulation Research, p. 1694-1707, 2021
Part of Proceedings of the National Academy of Sciences of the United States of America, p. 1895-1900, 2018
- DOI for Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria
- Download full text (pdf) of Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria
Part of European Journal of Clinical Investigation, p. 83-83, 2018
Perivascular macrophages regulate blood flow following tissue damage
Part of European Journal of Clinical Investigation, p. 44-45, 2018
Part of European Journal of Clinical Investigation, p. 79-79, 2018
Part of European Journal of Clinical Investigation, p. 79-79, 2018
Part of PLOS ONE, 2016
- DOI for In Vivo and In Vitro Detection of Luminescent and Fluorescent Lactobacillus reuteri and Application of Red Fluorescent mCherry for Assessing Plasmid Persistence
- Download full text (pdf) of In Vivo and In Vitro Detection of Luminescent and Fluorescent Lactobacillus reuteri and Application of Red Fluorescent mCherry for Assessing Plasmid Persistence
Part of Blood, p. 2016-2026, 2015
Part of Acta Physiologica, p. 200-209, 2015
- DOI for Shb deficiency in endothelium but not in leukocytes is responsible for impaired vascular performance during hindlimb ischemia.
- Download full text (pdf) of Shb deficiency in endothelium but not in leukocytes is responsible for impaired vascular performance during hindlimb ischemia.
Part of Cell Transplantation, p. 263-276, 2015
Part of Cell Transplantation, p. 263-276, 2015
Part of The FASEB Journal, 2014
Part of Brain, behavior, and immunity, p. 162-172, 2014
Part of Sleep, p. 195-198, 2014
Part of Cellular Signalling, p. 85-92, 2013
- DOI for Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells
- Download full text (pdf) of Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells
The mechanisms of VEGF-A-induced recruitment of pro-angiogenic neutrophils
Part of European Journal of Clinical Investigation, p. 27-27, 2013
Part of European Journal of Clinical Investigation, p. 9-9, 2013
Part of European Journal of Clinical Investigation, p. 27-27, 2013
Part of Blood, p. 4653-4662, 2012
Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency
Part of Angiogenesis, p. 469-480, 2012
- DOI for Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency
- Download full text (pdf) of Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency
Articles, review/survey
The discovery and development of topical medicines for wound healing
Part of Expert Opinion on Drug Discovery, p. 485-497, 2019
- DOI for The discovery and development of topical medicines for wound healing
- Download full text (pdf) of The discovery and development of topical medicines for wound healing